HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vaccine ...

DNA vaccines represent a versatile platform in which plasmid DNA encoding the SARS-CoV-2 spike antigen is delivered into host cells to elicit both antibody-mediated and T cell-mediated immunity. Rapid ...

Recently, Moderna has gained renewed attention for its mRNA technology after achieving positive results in personalized cancer vaccine trials. mRNA technology is establishing itself as a ...

A biotech that lost federal funding Tuesday following Health Secretary Robert F. Kennedy Jr.’s edict that his agency’s pandemic preparedness division stop funding development of messenger RNA-based ...

An international research team has identified a novel HIV antibody that targets the virus at a particularly vulnerable site and overcomes previous limitations of known antibodies. This study, led by ...

"Yellow fever is part of the history of Latin America, but we should not let vaccine shortages define its future," said Professor Jorge Osório, CEO of VaxThera. "This is what we set out to do when we ...

A newly developed nanoparticle-based vaccine successfully prevented melanoma, pancreatic, and triple-negative breast cancers in mice. The corresponding study was published in Cell Reports Medicine.

Industry leaders and experts from across the globe will meet in Amsterdam to discuss advancements in research and development processes within the evolving vaccine industry. The event will address 12 ...

Vaxxinity Inc positions itself as a biotechnology company aiming to develop vaccines and immunotherapies based on a modular peptide vaccine platform. The company’s approach seeks to train the immune ...

QUEBEC CITY, Feb. 17 /CNW/ - Medicago Inc. (TSX-V: MDG), a clinical-stage biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing ...

Vaxcyte remains in focus after recent clinical and pipeline updates around its pneumococcal vaccine program, a key catalyst for a US-listed biotech tied to respiratory disease prevention. Vaxcyte is ...